SEC 13F Intelligence

Peapack Gladstone Financial Corp / LLY

Peapack Gladstone Financial Corp’s Eli Lilly & Co Position

Does Peapack Gladstone Financial Corp own Eli Lilly & Co (LLY)? Yes — 77.4K shares worth $71M (+0.91% of its 13F portfolio) as of Q1 2026, down from 79.0K shares the prior filed quarter.

Position Value
$71M
Q1 2026
Shares
77.4K
% of Portfolio
+0.91%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $10MQ4 ’18Q1 ’19: $11MQ2 ’19: $9MQ3 ’19: $9MQ4 ’19: $11MQ4 ’19Q1 ’20: $11MQ2 ’20: $12MQ3 ’20: $10MQ4 ’20: $12MQ4 ’20Q1 ’21: $14MQ2 ’21: $17MQ3 ’21: $17MQ4 ’21: $22MQ4 ’21Q1 ’22: $22MQ2 ’22: $25MQ3 ’22: $30MQ4 ’22: $34MQ4 ’22Q1 ’23: $31MQ2 ’23: $39MQ3 ’23: $44MQ4 ’23: $46MQ4 ’23Q1 ’24: $60MQ2 ’24: $70MQ3 ’24: $65MQ4 ’24: $57MQ4 ’24Q1 ’25: $63MQ2 ’25: $62MQ3 ’25: $62MQ4 ’25: $85MQ4 ’25Q1 ’26: $71Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202677.4K$71M+0.91%
Q4 202579.0K$85M+1.07%
Q3 202580.9K$62M+0.80%
Q2 202579.4K$62M+0.88%
Q1 202576.0K$63M+0.93%
Q4 202474.1K$57M+0.83%
Q3 202473.6K$65M+0.94%
Q2 202476.9K$70M+1.07%
Q1 202477.2K$60M+0.94%
Q4 202378.1K$46M+0.77%
Q3 202381.7K$44M+0.81%
Q2 202382.2K$39M+0.69%
Q1 202387.8K$31M+0.58%
Q4 202291.9K$34M+0.66%
Q3 202293.5K$30M+0.62%
Q2 202276.0K$25M+0.56%
Q1 202277.5K$22M+0.43%
Q4 202179.4K$22M+0.41%
Q3 202172.0K$17M+0.34%
Q2 202174.0K$17M+0.41%
Q1 202175.1K$14M+0.36%
Q4 202070.7K$12M+0.36%
Q3 202066.2K$10M+0.36%
Q2 202073.8K$12M+0.48%
Q1 202076.0K$11M+0.50%
Q4 201980.5K$11M+0.43%
Q3 201983.7K$9M+0.40%
Q2 201985.1K$9M+0.41%
Q1 201985.3K$11M+0.50%
Q4 201885.4K$10M+0.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Peapack Gladstone Financial Corp’s full portfolio or all institutional holders of LLY.